MeVac - Meilahti Vaccine Research Center

Helsinki 00290

0 studies enrolling now · 3 studies all time

What they study most

Lyme Disease, Pneumococcal Disease, SARS-CoV-2 Infection, COVID-19

Studies at this site

• An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants — Completed